109 related articles for article (PubMed ID: 1957836)
1. Phase I study of flavone acetic acid (NSC 347512, LM975) in patients with pediatric malignant solid tumors.
Pratt CB; Relling MV; Meyer WH; Douglass EC; Kellie SJ; Avery L
Am J Clin Oncol; 1991 Dec; 14(6):483-6. PubMed ID: 1957836
[TBL] [Abstract][Full Text] [Related]
2. Phase I and pharmacology study of flavone acetic acid administered two or three times weekly without alkalinization.
de Forni M; Chabot GG; Armand JP; Gouyette A; Klink-Alak M; Recondo G
Cancer Chemother Pharmacol; 1995; 35(3):219-24. PubMed ID: 7805180
[TBL] [Abstract][Full Text] [Related]
3. Phase I clinical and pharmacokinetic study of flavopiridol in children with refractory solid tumors: a Children's Oncology Group Study.
Whitlock JA; Krailo M; Reid JM; Ruben SL; Ames MM; Owen W; Reaman G;
J Clin Oncol; 2005 Dec; 23(36):9179-86. PubMed ID: 16361620
[TBL] [Abstract][Full Text] [Related]
4. A phase I and pharmacokinetic study of 12-h infusion of flavone acetic acid.
Olver IN; Webster LK; Bishop JF; Stokes KH
Cancer Chemother Pharmacol; 1992; 29(5):354-60. PubMed ID: 1551173
[TBL] [Abstract][Full Text] [Related]
5. Clinical and pharmacokinetic phase I trial with the diethylaminoester of flavone acetic acid (LM985, NSC 293015).
Dodion PF; Abrams J; Gérard B; Crespeigne N; Peeters B; Van Berchem C; Kenis Y
Eur J Cancer Clin Oncol; 1987 Jun; 23(6):837-42. PubMed ID: 3653200
[TBL] [Abstract][Full Text] [Related]
6. Phase I and pharmacokinetic study of flavone acetic acid.
Kerr DJ; Kaye SB; Cassidy J; Bradley C; Rankin EM; Adams L; Setanoians A; Young T; Forrest G; Soukop M
Cancer Res; 1987 Dec; 47(24 Pt 1):6776-81. PubMed ID: 3677106
[TBL] [Abstract][Full Text] [Related]
7. Phase I and clinical pharmacology study of intravenous flavone acetic acid (NSC 347512).
Weiss RB; Greene RF; Knight RD; Collins JM; Pelosi JJ; Sulkes A; Curt GA
Cancer Res; 1988 Oct; 48(20):5878-82. PubMed ID: 3167843
[TBL] [Abstract][Full Text] [Related]
8. Phase II trials with flavone acetic acid (NCS. 347512, LM975) in patients with advanced carcinoma of the breast, colon, head and neck and melanoma.
Kaye SB; Clavel M; Dodion P; Monfardini S; ten Bokkel-Huinink W; Wagener DT; Gundersen S; Stoter G; Smith J; Renard J
Invest New Drugs; 1990; 8 Suppl 1():S95-9. PubMed ID: 2380021
[TBL] [Abstract][Full Text] [Related]
9. Phase II trials of flavone acetic acid in advanced malignant melanoma and colorectal carcinoma.
Kerr DJ; Maughan T; Newlands E; Rustin G; Bleehen NM; Lewis C; Kaye SB
Br J Cancer; 1989 Jul; 60(1):104-6. PubMed ID: 2803908
[TBL] [Abstract][Full Text] [Related]
10. Flavone acetic acid distribution in human malignant tumors.
Damia G; Freschi A; Sorio R; Braida A; Caruso G; Quaia M; Monfardini S; D'Incalci M
Cancer Chemother Pharmacol; 1990; 26(1):67-70. PubMed ID: 2322990
[TBL] [Abstract][Full Text] [Related]
11. Phase I trial of continuous infusion flavopiridol, a novel cyclin-dependent kinase inhibitor, in patients with refractory neoplasms.
Senderowicz AM; Headlee D; Stinson SF; Lush RM; Kalil N; Villalba L; Hill K; Steinberg SM; Figg WD; Tompkins A; Arbuck SG; Sausville EA
J Clin Oncol; 1998 Sep; 16(9):2986-99. PubMed ID: 9738567
[TBL] [Abstract][Full Text] [Related]
12. Phase I clinical and pharmacokinetic trial of flavone acetic acid.
Havlin KA; Kuhn JG; Craig JB; Boldt DH; Weiss GR; Koeller J; Harman G; Schwartz R; Clark GN; Von Hoff DD
J Natl Cancer Inst; 1991 Jan; 83(2):124-8. PubMed ID: 1703237
[TBL] [Abstract][Full Text] [Related]
13. Phase II trial with Flavone Acetic Acid (NSC.347512, LM975) in patients with non-small cell lung cancer.
Siegenthaler P; Kaye SB; Monfardini S; Renard J
Ann Oncol; 1992 Feb; 3(2):169-70. PubMed ID: 1318743
[No Abstract] [Full Text] [Related]
14. Phase I and pharmacokinetic study of gefitinib in children with refractory solid tumors: a Children's Oncology Group Study.
Daw NC; Furman WL; Stewart CF; Iacono LC; Krailo M; Bernstein ML; Dancey JE; Speights RA; Blaney SM; Croop JM; Reaman GH; Adamson PC;
J Clin Oncol; 2005 Sep; 23(25):6172-80. PubMed ID: 16135484
[TBL] [Abstract][Full Text] [Related]
15. Phase I and pharmacokinetic study of LM985 (flavone acetic acid ester).
Kerr DJ; Kaye SB; Graham J; Cassidy J; Harding M; Setanoians A; McGrath JC; Vezin WR; Cunningham D; Forrest G
Cancer Res; 1986 Jun; 46(6):3142-6. PubMed ID: 3698028
[TBL] [Abstract][Full Text] [Related]
16. Phase I trial and pharmacokinetic study of pyrazoloacridine in children and young adults with refractory cancers.
Berg SL; Blaney SM; Adamson PC; O'Brien M; Poplack DG; Arndt C; Blatt J; Balis FM
J Clin Oncol; 1998 Jan; 16(1):181-6. PubMed ID: 9440741
[TBL] [Abstract][Full Text] [Related]
17. Pharmacodynamics and causes of dose-dependent pharmacokinetics of flavone-8-acetic acid (LM-975; NSC-347512) in mice.
Chabot GG; Bissery MC; Corbett TH; Rutkowski K; Baker LH
Cancer Chemother Pharmacol; 1989; 24(1):15-22. PubMed ID: 2597279
[TBL] [Abstract][Full Text] [Related]
18. Flavone acetic acid (FAA) with recombinant interleukin-2 (rIL-2) in advanced malignant melanoma. IV: Pharmacokinetics and toxicity of flavone acetic acid and its metabolites.
Stratford MR; Rustin GJ; Dennis MF; Watfa RR; Howells N; O'Reilly SM
Br J Cancer; 1993 Jun; 67(6):1351-5. PubMed ID: 8512820
[TBL] [Abstract][Full Text] [Related]
19. Phase I clinical and pharmacokinetic study of plitidepsin as a 1-hour weekly intravenous infusion in patients with advanced solid tumors.
Izquierdo MA; Bowman A; García M; Jodrell D; Martinez M; Pardo B; Gómez J; López-Martin JA; Jimeno J; Germá JR; Smyth JF
Clin Cancer Res; 2008 May; 14(10):3105-12. PubMed ID: 18483378
[TBL] [Abstract][Full Text] [Related]
20. Phase II evaluation of topotecan for pediatric central nervous system tumors.
Blaney SM; Phillips PC; Packer RJ; Heideman RL; Berg SL; Adamson PC; Allen JC; Sallan SE; Jakacki RI; Lange BJ; Reaman GH; Horowitz ME; Poplack DG; Balis FM
Cancer; 1996 Aug; 78(3):527-31. PubMed ID: 8697400
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]